Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials.
- DOI
- 10.1016/j.radonc.2017.10.017
- Published
- 2018 Mar
- Container
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.radonc.2017.10.017,
title = {Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials.},
author = {de Haan R and Pluim D and van Triest B and van den Heuvel M and Peulen H and van Berlo D and George J and Verheij M and Schellens JHM and Vens C},
year = {2018},
journal = {Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
doi = {10.1016/j.radonc.2017.10.017},
url = {https://doi.org/10.1016/j.radonc.2017.10.017}
}RIS
TY - JOUR TI - Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials. AU - de Haan R AU - Pluim D AU - van Triest B AU - van den Heuvel M AU - Peulen H AU - van Berlo D AU - George J AU - Verheij M AU - Schellens JHM AU - Vens C PY - 2018 JO - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology DO - 10.1016/j.radonc.2017.10.017 UR - https://doi.org/10.1016/j.radonc.2017.10.017 ER -
APA
R, D. H., D, P., B, V. T., M, V. D. H., H, P., D, V. B., J, G., M, V., JHM, S., & C, V. (2018). Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. https://doi.org/10.1016/j.radonc.2017.10.017
Source records
- pubmed · retrieved 2026-09-25T01:56:42.301Z